About Theragenics (NYSE:TGX)
Theragenics Corporation is a medical device company serving the surgical products and cancer treatment markets. The Company operates in two business segments: surgical products segment and brachytherapy seed segment. The Company's surgical products business manufactures, markets and sells disposable devices primarily utilized in certain surgical procedures. The Company's brachytherapy seed business manufactures, markets and sells radioactive seeds primarily utilized in the treatment of early stage prostate cancer. The Company designs , manufactures, assembles, packages and distributes its surgical products in three primary production facilities, each of which manufactures different products. In October 2013, the Company announced that it has completed the merger with Juniper Acquisition Corporation.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Theragenics (NYSE:TGX) Frequently Asked Questions
What is Theragenics' stock symbol?
Theragenics trades on the New York Stock Exchange (NYSE) under the ticker symbol "TGX."
Who are some of Theragenics' key competitors?
Some companies that are related to Theragenics include Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE), Novartis (NVS), Roche (ROG), AbbVie (ABBV), Merck & Co., Inc. (MRK), Amgen (AMGN), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Abbott Laboratories (ABT), GlaxoSmithKline (GSK), Thermo Fisher Scientific (TMO), AstraZeneca (AZN), Sanofi (SAN), Bayer (BAYN), Celgene (CELG) and CSL (CSL).
How do I buy Theragenics stock?
Shares of Theragenics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Theragenics' stock price today?
One share of Theragenics stock can currently be purchased for approximately $0.01.
How can I contact Theragenics?
Theragenics' mailing address is 5203 Bristol Industrial Way, BUFORD, GA 30518, United States. The medical device company can be reached via phone at +1-770-8315137.
MarketBeat Community Rating for Theragenics (TGX)MarketBeat's community ratings are surveys of what our community members think about Theragenics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Theragenics (NYSE:TGX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Theragenics (NYSE:TGX) Earnings History and Estimates Chart
Theragenics (NYSE TGX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/8/2013||Q2 2013||$0.03||$21.96 million||$20.30 million||View||N/A|
|2/14/2013||Q4 2012||($0.01)||$19.88 million||$19.10 million||View||Listen|
|11/8/2012||Q312||$0.02||$20.50 million||$19.92 million||View||N/A|
Theragenics (NYSE:TGX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Theragenics (NYSE:TGX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Theragenics (NYSE TGX)
No insider trades for this company have been tracked by MarketBeat.com
Theragenics (NYSE TGX) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Theragenics (NYSE:TGX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Theragenics (NYSE:TGX) Income Statement, Balance Sheet and Cash Flow Statement
Theragenics (NYSE TGX) Stock Chart for Saturday, February, 24, 2018